[Advances in the study of Cantharidin and its derivatives].
Liu
Jian
J
Shenyang Pharmaceutical University, Shenyang 110016, Liaoning, China
Gao
Jianhui
J
Liu
Xiaoqiu
X
D000818:Animals; D000970:Antineoplastic Agents / Q000302:isolation & purification / Q000494:pharmacology*; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000302:isolation & purification / Q000494:pharmacology; D002193:Cantharidin / Q000302:isolation & purification / Q000494:pharmacology*; D001517:Coleoptera / Q000737:chemistry*; D006801:Humans; D007959:Lymphocyte Culture Test, Mixed; D008419:Materia Medica / Q000302:isolation & purification / Q000494:pharmacology*
D000970:Antineoplastic Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; D008419:Materia Medica; C069741:norcantharidin; D002193:Cantharidin